Sebomed - basal medium for human sebocyte cells
The modified DMEM/Ham’s F-12 (1:1) was optimized to grow the human sebaceous gland cell line SZ95 in vitro. The cell line itself was developed by transfecting primary human facial sebocytes. A defined medium formulation allows detailed studies under controlled conditions on the influence of hormones, cytokines, lipids, and drugs on human sebocytes. The formulation is patent protected, and available on request.